UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
|
Date of Report (Date of earliest event reported): June 12, 2024 |
ROCKET LAB USA, INC.
(Exact name of Registrant as Specified in Its Charter)
| | | | |
Delaware | 001-39560 | 98-1550340 |
(State or Other Jurisdiction of Incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
| | | | |
3881 McGowen Street | |
Long Beach, California | | 90808 |
(Address of Principal Executive Offices) | | (Zip Code) |
|
Registrant’s Telephone Number, Including Area Code: 714 465-5737 |
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
| | | | |
Title of each class
| | Trading Symbol(s) | | Name of each exchange on which registered
|
Common Stock, par value $0.0001 per share | | RKLB | | The Nasdaq Stock Market LLC |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.07 Submission of Matters to a Vote of Security Holders.
(a)-(b) On June 12, 2024, Rocket Lab USA, Inc. (the “Company”) held its 2024 Annual Meeting of Stockholders (the “Meeting”). As of the record date of April 16, 2024 (the “record date”), there were 492,683,716 shares of the Company’s common stock, $0.0001 par value (“Common Stock”), outstanding (each entitled to one vote per share). Of the total 492,683,716 shares of the Company’s Common Stock outstanding as of the record date, 352,859,013 shares were represented at the Meeting. The Company’s stockholders considered three proposals at the Meeting, each of which is described in more detail in the Company’s definitive proxy statement filed with the Securities and Exchange Commission on April 24, 2024. The number of votes cast for and against (or withheld) and the number of abstentions and broker non-votes with respect to each proposal voted upon are set forth below.
| | |
| | |
Proposal 1. | | The stockholders elected two Class III directors to hold office for a three-year term expiring at the 2027 annual meeting of stockholders and until their respective successors are duly elected and qualified, by the following vote: |
| | | | | | | | | |
Name of Directors Elected | | For | | Withhold | | Broker Non-Votes |
Lt. Gen. Nina M. Armagno (Ret.) | | | 248,478,144 | | | 1,184,794 | | | 103,196,075 |
Peter Beck | | | 234,810,322 | | | 14,852,616 | | | 103,196,075 |
| | |
Proposal 2. | | The stockholders ratified the appointment of Deloitte & Touche LLP to serve as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024, by the following vote: |
| | | | |
For | | Against | | Abstain |
350,790,323 | | 1,010,170 | | 1,058,520 |
| | |
Proposal 3. | | The stockholders approved, on a non-binding advisory basis, the compensation of our named executive officers disclosed in the Company’s definitive proxy statement, based upon the votes set forth in the table below: |
| | | | | | |
For | | Against | | Abstain | | Broker Non-Votes |
245,635,450 | | 3,098,739 | | 928,749 | | 103,196,075 |
There were no broker non-votes with respect to Proposal 2.
No other items were presented for stockholder approval at the Meeting.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | | |
| | | ROCKET LAB USA, INC. |
| | | |
Date: | June 14, 2024 | By: | /s/ Arjun Kampani |
| | | Arjun Kampani Senior Vice President, General Counsel, and Corporate Secretary |